The diabetic footwear market is estimated to be valued at USD 8.92 Bn in 2024, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. The global diabetic footwear market has been witnessing significant growth over the past few years, driven by the rising global prevalence of diabetes. Diabetes-related foot complications are a major healthcare concern as unhealthy footwear can increase pressure points and risk of foot ulcers and amputations. Adoption of specially designed therapeutic shoes has increased among diabetes patients to effectively manage their footwear needs. These shoes are often prescribed by podiatrists to reduce pressure and trauma on feet. Advancements in materials and technologies have enabled manufacturers to offer customized, high-performance diabetic shoes for improving comfort levels and gait. Various awareness initiatives by health organizations regarding the importance of proper footwear and foot care are further boosting demand.

 Market Dynamics:

The global diabetic footwear market is expected to register lucrative growth over the forecast period owing to rising factors such as growing geriatric population, increasing obesity rates, and diabetes management initiatives worldwide. According to recent studies, around 463 million adults are suffering from diabetes globally, and this number is projected to surpass 700 million by 2045. Favorable reimbursement policies for therapeutic shoes in developed countries are also propelling the market growth. However, higher costs compared to regular shoes along with lack of awareness in low-income nations remains key challenges. Nevertheless, market players are coming up with affordable product options to tap opportunities in developing markets. Ongoing research for advanced textile materials and foot scanner technologies offer new prospects for industry participants.

Key Features of the Study:

• This report provides in-depth analysis of the global diabetic footwear market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diabetic footwear market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Enovis companies, Pilgrim Shoes, Drew Shoe, Casa Everz Gmbh, DARCO Medical India Pvt. Ltd., Anodyne, Apis Footwear Company, Propét USA, Inc., Pedors247, Reed Medical Ltd, Oasis Footwear, Podartis Srl, Aetrex Worldwide, DJO Global Inc., Dr. Zen Products, Inc., and Orthofeet Inc
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global diabetic footwear market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic footwear market

Detailed Segmentation-

• By Product Type:
• • Sandals
  • Shoes
  • Slippers
• By Distribution Channel:
• • Offline
  • Online
• By Region:
• • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
• • Enovis companies
  • Pilgrim Shoes
  • Drew Shoe
  • Casa Everz Gmbh
  • DARCO Medical India Pvt. Ltd.
  • Anodyne
  • Apis Footwear Company
  • Propét USA, Inc.
  • Pedors247
  • Reed Medical Ltd
  • Oasis Footwear
  • Podartis Srl
  • Aetrex Worldwide
  • DJO Global Inc.
  • Dr. Zen Products, Inc.
  • Orthofeet Inc